The most significant observations refer to the appearance of autoantibodies to IL-17 or IL-22 and increase susceptibility to chronic mucocutaneous candidiasis (CMC) (61, 62), as these cytokines have a major role in protecting against CMC. This evidence concerns the gene IL22 and chronic mucocutaneous candidiasis.